Infectious Bursal Disease Live Vaccine for Poultry

Varieties: Infectious Disease Prevention Medicine
Component: Vaccine
Type: The First Class
Pharmacodynamic Influential Factors: Animal Species
Storage Method: Store at Low Temperature and Avoid Light
Transport Package: White Plastic Bottle
Manufacturer/Factory & Trading Company
Gold Member Since 2014

Suppliers with verified business licenses

Beijing, China
to see all verified strength labels (11)

Basic Info.

Specification
100ml, 250ml
Trademark
Beijing centre
Origin
Beijing

Product Description

Infectious bursal disease (IBD), also known as Gumboro diseaseinfectious bursitis and infectious avian nephrosis, is a highly contagious disease of young chickens and turkeys caused by infectious bursal disease virus (IBDV), characterized by immunosuppression and mortality generally at 3 to 6 weeks of age. The disease was first discovered in Gumboro, Delaware in 1962. It is economically important to the poultry industry worldwide due to increased susceptibility to other diseases and negative interference with effective vaccination. In recent years, very virulent strains of IBDV (vvIBDV), causing severe mortality in chicken, have emerged in Europe, Latin America, South-East Asia, Africa and the Middle East. Infection is via the oro-fecal route, with affected bird excreting high levels of the virus for approximately 2 weeks after infection. The disease is easily spread from infected chickens to healthy chickens through food, water, and physical contact.

Virology
IBDV is a double-stranded RNA virus that has a bi-segmented genome and belongs to the genus Avibirnavirus of family Birnaviridae. There are two distinct serotypes of the virus, but only serotype 1 viruses cause disease in poultry.[3] At least six antigenic subtypes of IBDV serotype 1 have been identified by in vitro cross-neutralization assay. Viruses belonging to one of these antigenic subtypes are commonly known as variants, which were reported to break through high levels of maternal antibodies in commercial flocks, causing up to 60 to 100 percent mortality rates in chickens. With the advent of highly sensitive molecular techniques, such as reverse transcription polymerase chain reaction (RT-PCR) and restriction fragment length polymorphism (RFLP), it became possible to detect the vvIBDV, to differentiate IBDV strains, and to use such information in studying the molecular epidemiology of the virus.

Pathogenesis
Clinical disease is associated to bird age with the greatest bursal mass, which occurs between 3 and 6 weeks of age. The greatest bursal mass is mostly a result of a large population of maturing IgM-bearing B-lymphocytes (lymphoblasts), the main target of infection. Young birds at around two to eight weeks of age that have highly active bursa of Fabricius are more susceptible to disease. Birds over eight weeks are resistant to challenge and will not show clinical signs unless infected by highly virulent strains.

Subclinical disease occurs in chickens infected before three weeks of age. At this age the B-lymphoblast population is smaller and the systemic effects are insufficient for generating clinical signs. However, the B-cell destruction is usually most severe in subclinically infected young, as virus will destroy a smaller population and most cells in one place (the bursa).

After ingestion, the virus destroys the lymphoid follicles in the bursa of Fabricius as well as the circulating B-cells in the secondary lymphoid tissues such as GALT (gut-associated lymphoid tissue), CALT (conjunctiva), BALT (Bronchial) caecal tonsils, Harderian gland, etc. Acute disease and death is due to the necrotizing effect of these viruses on the host tissues. Kidney failure is a common cause of mortality. If the bird survives and recovers from this phase of the disease, it remains immunocompromised which means it is more susceptible to other diseases.

1. Our company is established in 1999. It  is a high-technology group specializing in researching,developing,manufacturing and selling animal health care products and providing technical service for breeding and administration.

2. Qualified company for EUROPE FAMIQS Certificate for Herbal Products, and international ISO 9001 and ISO 14001.

3. Board Chairman Unit of Beijing Veterinary Association

4. Our products have been exported to more than 50 countries in Asia, Europe, Africa, and South America, such as Janpan, Sudan, Italy, Portugal, Croatia, etc.

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Gold Member Since 2014

Suppliers with verified business licenses

Manufacturer/Factory & Trading Company
Main Products
Veterinary Medicine, Herbal Medicine, Vaccine, Feed Additives
Number of Employees
103